Your browser doesn't support javascript.
loading
A multicenter clinical study: personalized medication for advanced gastrointestinal carcinomas with the guidance of patient-derived tumor xenograft (PDTX).
Cheng, Yuan; Qin, Shu-Kui; Li, Jin; Dai, Guang-Hai; Shen, Bai-Yong; Ying, Jie-Er; Ba, Yi; Liang, Han; Wang, Xin-Bo; Xu, Ye; Zhou, Lin; Ding, Ke-Feng; Qin, Yan-Ru; Yang, Shu-Jun; Guan, Wen-Xian; Zheng, Hui; Wang, Qian; Song, Hang; Zhu, Yan-Ping.
Afiliação
  • Cheng Y; Bayi Hospital Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
  • Qin SK; Bayi Hospital Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China. qinsk@csco.org.cn.
  • Li J; Shanghai East Hospital Affiliated to Tongji University, Shanghai, China. fudanlijin@163.com.
  • Dai GH; Chinese PLA General Hospital, Beijing, China.
  • Shen BY; Shanghai Ruijin Hospital, Shanghai, China.
  • Ying JE; Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China.
  • Ba Y; Tianjin Cancer Hospital, Tianjin, China.
  • Liang H; Tianjin Cancer Hospital, Tianjin, China.
  • Wang XB; Eastern Theater General Hospital of Chinese PLA, Nanjing, Jiangsu, China.
  • Xu Y; Shanghai Cancer Hospital, Shanghai, China.
  • Zhou L; 302 Military Hospital of Chinese PLA, Beijing, China.
  • Ding KF; The Second Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang, China.
  • Qin YR; The First Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang, China.
  • Yang SJ; Henan Cancer Hospital, Zhengzhou, Henan, China.
  • Guan WX; Drum Tower Hospital Affiliated to Nanjing University School of Medicine, Nanjing, Jiangsu, China.
  • Zheng H; Nanjing Personal Oncology Biological Technology Co. Ltd, Nanjing, Jiangsu, China.
  • Wang Q; Nanjing Personal Oncology Biological Technology Co. Ltd, Nanjing, Jiangsu, China.
  • Song H; Nanjing Personal Oncology Biological Technology Co. Ltd, Nanjing, Jiangsu, China.
  • Zhu YP; Nanjing Personal Oncology Biological Technology Co. Ltd, Nanjing, Jiangsu, China.
J Cancer Res Clin Oncol ; 148(3): 673-684, 2022 Mar.
Article em En | MEDLINE | ID: mdl-33864522
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Regulação Neoplásica da Expressão Gênica / Neoplasias Gastrointestinais / Antineoplásicos Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Regulação Neoplásica da Expressão Gênica / Neoplasias Gastrointestinais / Antineoplásicos Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article